Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab
Saskia Räuber(University of Münster), David Kremer(Heinrich Heine University Düsseldorf), Karin von Wnuck Lipinski(Heinrich Heine University Düsseldorf), Philipp Albrecht(Heinrich Heine University Düsseldorf), Jens Ingwersen(Heinrich Heine University Düsseldorf), Melanie Korsen(Heinrich Heine University Düsseldorf), Christina B. Schroeter(University of Münster), Niklas Huntemann(University Hospital Münster), Bianca Teegen(Mayo Clinic), Sven G. Meuth(University of Würzburg), Tristan Kölsche(Heinrich Heine University Düsseldorf), Liesa Regner-Nelke(Heinrich Heine University Düsseldorf), Orhan Aktaş(Heinrich Heine University Düsseldorf), Tobias Ruck(University Hospital Münster), Christopher Nelke(University of Münster), Hans‐Peter Hartung(The University of Sydney), Nico Melzer(University of Würzburg), Marc Pawlitzki(University Hospital Münster), Michael Barnett(The University of Sydney), Leoni Rolfes(University Hospital Münster), Vera Dobelmann(Heinrich Heine University Düsseldorf), Alexander Hermann(Heinrich Heine University Düsseldorf), Bodo Levkau(Düsseldorf University Hospital), Thomas Müntefering(Heinrich Heine University Düsseldorf)
Cited by 30
Related Papers
Effects of dimethyl fumarate on neuroprotection and immunomodulation
|Journal of Neuroinflammation|2012|223
APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies
|Neurology|2021|217
Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid
|Immunity|2020|187
Sublethal necroptosis signaling promotes inflammation and liver cancer
|Immunity|2023|133